Search 

Meet Axol Bioscience at the UK Pavilion (Hall B, Stand 2348).

We support your pursuit of more effective, safer therapies. Like you, we believe that having more human-relevant disease models will expand scientificknowledge and de-risk drug development. We usehuman iPSCs to achieve this and have been doingso since 2006.We use donated cells from patients and iPSC technology to build physiologically relevant in vitromodels.

We have a special focus on neurodegenerative diseases like Alzheimer’s disease as well ascardiotoxicity to promote drug safety. When working with candidate compounds or novel therapies, our in vitro platforms give you betterearlier-stage modeling and safety testing and later-stage efficacy evaluation and improved patientselection.

With these data comes better insights, helping you de-risk projects, reduce costs, and save timeduring drug development.At Axol Bioscience, we help your science with better models of human disease.

Meet Cancer Research Horizons at the UK Pavilion (Hall B, Stand 2348).

Cancer Research Horizons is the innovation arm of Cancer Research UK – the world's largest charitable funder of cancer research. We bring together world-leading minds, bold ideas and the right partners to bridge the gap between academic research and taking drugs to market. We focus on the tougher, more profound ideas that can lead to true innovation, translating them into effective treatments and diagnostics for cancer patients.

To date, we've played an instrumental role in forming over 60 spin-out companies. We've helped bring 11 cancer drugs to market, borne out of Cancer Research UK's pioneering research. Through these drugs, we have enabled in excess of 6 million courses of treatment for cancer patients across the world. With access to Cancer Research UK's network of 4000 exceptional researchers and clinicians, and £300+ million of annual research spend, we're a powerful partner in the fight to conquer cancer.

Meet The Cell and Gene Therapy Catapult at the UK Pavilion (Hall B, Stand 2348). 

The Cell and Gene Therapy Catapult is an independent innovation and technology organisation committed to the advancement of cell and gene therapies with a vision of a thriving industry delivering life changing advanced therapies to the world. Its aim is to create powerful collaborations which overcome challenges to the advancement of the sector. With over 400 experts covering all aspects of advanced therapies, it applies its unique capabilities and assets, collaborates with academia, industry and healthcare providers to develop new technology and innovation. The Cell and Gene Therapy Catapult works with Innovate UK.